Key facts
- Wellumio’s last known valuation is $14.1M (Jun 2023).
- It has raised $16.9M; the latest was Later Stage VC ($7.3M) in Feb 2026.
- Notable investors include Icehouse Ventures, Enterprise Angels, New Zealand Growth Capital Partners, Aspire NZ Seed Fund, Booster Innovation Fund — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Wellumio
- ·The full record, as it builds
Funding rounds
No funding rounds for Wellumio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Wellumio
Developer of a portable MRI platform intended to eliminate the risk of acute stroke. The company's platform uses computed tomography technology for rapid and accurate diagnosis of stroke and revolutionizes stroke treatment by shortening the treatment period, enabling healthcare sectors to reduce the health impact of stroke across all communities and the economic burden to health systems.
- Sector
- Healthcare
- HQ
- Wellington, New Zealand
- Founded
- 2019
- Employees
- 5
- Website
- wellumio.com/
- Ownership
- Privately Held (backing)
Wellumio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wellumio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wellumio in its N-PORT filings yet. We sweep new filings monthly.